Effect of medial parapatellar versus modified V-Y quadricepsplasty approach on knee function and quadriceps strength in revision knee arthroplasty
Archives of Orthopaedic and Trauma Surgery · 2026
DOI: 10.1007/s00402-026-06204-8 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Archives of Orthopaedic and Trauma Surgery, 2026. Verfasst von Mehmet Melih Asoglu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Şanlıurfa Metrolife Hospital, Şanlıurfa, Turkey. melihasoglu@hotmail.com. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Muscle Strength, Quadriceps Muscle, Knee Joint. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
PURPOSE: This study aimed to compare the clinical and functional outcomes of modified V-Y quadricepsplasty with those of medial parapatellar (MP) arthrotomy in the context of revision total knee arthroplasty (rTKA). It is hypothesized that there is no significant difference in clinical, radiological, and strength outcomes between V-Y quadricepsplasty and the medial parapatellar approach. MATERIALS AND METHODS: A retrospective comparative cohort study was conducted on 31 patients (19 who underwent an MP arthrotomy and 12 who underwent a modified V-Y quadricepsplasty) who had undergone rTKA. The clinical outcomes included knee range of motion (ROM), muscle strength, and functional scores (HSS, LEFS, WOMAC). Radiographic evaluations were conducted to assess mechanical axis deviation (MAD) and patellar height. RESULTS: Both groups were comparable in demographics. Clinical outcomes, including active ROM (89.5° ± 22.2° vs. 89.4° ± 8.9°; p = 0.985), extension deficit (0.41° ± 1.44° vs. 4.7° ± 7.5°; p = 0.061), flexion (93.7° ± 24.4° vs. 106.3° ± 16.7°; p = 0.099), and functional scores (HSS: 82.6 ± 12.1 vs. 85.8 ± 9.2, p = 0.408; LEFS: 43.4 ± 11.8 vs. 45.2 ± 12.2, p = 0.691; WOMAC: 24.3 ± 12.9 vs. 20.7 ± 17.3, p = 0.543) were similar between groups. Strength measurements showed no significant differences in peak extension (38.3 ± 16.8 Nm vs. 39.3 ± 12.9 Nm; p= 0.848) and peak flexion torque (22.6 ± 6.7 Nm vs. 24.8 ± 6.8 Nm; p = 0.392). Radiographic assessments showed no significant differences in MAD (15.4 ± 19.5 mm vs. 15.8 ± 13.6 mm; p = 0.951) and patellar height (1.1 ± 0.14 vs. 1.14 ± 0.25; p = 0.669). No complications were observed. CONCLUSIONS: Modified V-Y quadricepsplasty offers outcomes comparable to MP arthrotomy in rTKA, with the advantage of extended exposure for complex cases without compromising recovery. However, given the limited sample size and the exploratory nature of this study, these findings should not be interpreted as evidence of equivalence between the two approaches. LEVEL OF EVIDENCE: Level IV, Retrospective cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Şanlıurfa Metrolife Hospital, Şanlıurfa, Turkey. melihasoglu@hotmail.com.
- Antalya Eğitim ve Araştırma Hastanesi, Antalya, Turkey.
- Antalya City Hospital, Antalya, Turkey.
Zitieren
APA
Asoglu, M. M., Unal, M., Kartal, E. M., Aktan, C., May, H., & Guler, F. (2026). Effect of medial parapatellar versus modified V-Y quadricepsplasty approach on knee function and quadriceps strength in revision knee arthroplasty. Archives of Orthopaedic and Trauma Surgery. https://doi.org/10.1007/s00402-026-06204-8
Vancouver
Asoglu MM, Unal M, Kartal EM, Aktan C, May H, Guler F. Effect of medial parapatellar versus modified V-Y quadricepsplasty approach on knee function and quadriceps strength in revision knee arthroplasty. Archives of Orthopaedic and Trauma Surgery. 2026. doi:10.1007/s00402-026-06204-8
BibTeX
@article{Asoglu2026,
author = {Asoglu, Mehmet Melih and Unal, Melih and Kartal, Emre Mucahit and Aktan, Cemil and May, Hasan and Guler, Ferhat},
title = {Effect of medial parapatellar versus modified V-Y quadricepsplasty approach on knee function and quadriceps strength in revision knee arthroplasty},
journal = {Archives of Orthopaedic and Trauma Surgery},
year = {2026},
doi = {10.1007/s00402-026-06204-8}
}
EUVIMED